THE FIBRINOLYTIC SYSTEM IN DIABETES-MELLITUS

被引:49
作者
GOUGH, SCL [1 ]
GRANT, PJ [1 ]
机构
[1] UNIV LEEDS,GEN INFIRM,DEPT MED,MARTIN WING,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
关键词
FIBRINOLYTIC SYSTEM; DIABETES; PLASMINOGEN ACTIVATOR INHIBITOR-1;
D O I
10.1111/j.1464-5491.1991.tb01527.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:898 / 905
页数:8
相关论文
共 77 条
[1]  
Rijkin DC, Wijngaards G., Welbergen J., Immunological characterization of plasminogen activator activities in human tissue and body fluids, J Lab Clin Med, 97, pp. 477-486, (1981)
[2]  
Aoki N., Von Kaulla KN, Dissimilarity of human vascular plasminogen activator and human urokinase, J Lab Clin Med, 78, pp. 354-362, (1971)
[3]  
Bachman F., Fibrinolysis, Thrombosis and Haemostasis, pp. 227-265, (1987)
[4]  
Kruithof EKO, Plasminogen activator inhibitors—a review, Enzyme, 40, pp. 113-121, (1988)
[5]  
Booth NA, Anderson JA, Bennett B., Platelet release protein which inhibits plasminogen activators, J Clin Pathol, 38, pp. 825-830, (1985)
[6]  
Astedt B., Hagerstrand I., Lecander I., Cellular localisation in placenta of placental type plasminogen activator inhibitor, Thromb Haemost, 56, pp. 63-65, (1986)
[7]  
Kruithof EKO, Tran-Thang C., Gudinchet A., Hauert J., Nicoloso G., Genton C., Et al., Fibrinolysis in pregnancy. A study of plasminogen activator inhibitors, Blood, 69, pp. 460-466, (1987)
[8]  
Kruithof EKO, Vassalli J-D, Schleuning W-D, Mattaliano RJ, Bachmann F., Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell‐line U937, J Biol Chem, 261, pp. 11207-11213, (1986)
[9]  
Cajot J-F, Kruithof EKO, Schleuning W-D, Sordat B., Bachmann F., Plasminogen activators, plasminogen activator inhibitors and procoagulant, analyzed in twenty human tumour cell lines, Int J Cancer, 38, pp. 719-727, (1986)
[10]  
Kruithof EKO, Gudinchet A., Bachmann F., Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states, Thromb Haemost, 59, pp. 7-12, (1988)